A recombinant-based feline immunodeficiency virus antibody enzyme-linked immunosorbent assay

1992 ◽  
Vol 35 (1-2) ◽  
pp. 133-141 ◽  
Author(s):  
B. Mermer ◽  
P. Hillman ◽  
R. Harris ◽  
T. Krogmann ◽  
Q. Tonelli ◽  
...  
Keyword(s):  
Immunosorbent Assay ◽  
Feline Immunodeficiency Virus ◽  
Enzyme Linked Immunosorbent Assay ◽  
Virus Antibody ◽  
Immunodeficiency Virus

scholarly journals Vaccination with an Inactivated Virulent Feline Immunodeficiency Virus Engineered To Express High Levels of Env

2005 ◽  
Vol 79 (3) ◽  
pp. 1954-1957 ◽  
Author(s):  
Margaret J. Hosie ◽  
Dieter Klein ◽  
James Μ. Binley ◽  
Thomas H. Dunsford ◽  
Oswald Jarrett ◽  
...  
Keyword(s):  
Immunosorbent Assay ◽  
Virus Vaccine ◽  
Feline Immunodeficiency Virus ◽  
Envelope Glycoprotein ◽  
Enzyme Linked Immunosorbent Assay ◽  
Sorting Signal ◽  
Pathogenic Isolate ◽  
Immunodeficiency Virus ◽  
Endocytic Sorting

ABSTRACT An inactivated virus vaccine was prepared from a pathogenic isolate of feline immunodeficiency virus containing a mutation that eliminated an endocytic sorting signal in the envelope glycoprotein, increasing its expression on virions. Cats immunized with inactivated preparations of this modified virus exhibited strong titers of antibody to Env by enzyme-linked immunosorbent assay. Evidence of protection following challenge demonstrated the potential of this approach to lentiviral vaccination.

Vaccine Site-Associated Sarcoma and Malignant Lymphoma in Cats: A Report of Six Cases (1997–2002)

2004 ◽  
Vol 40 (1) ◽  
pp. 47-50 ◽  
Author(s):  
Bruce R. Madewell ◽  
Tracy L. Gieger ◽  
Patricia A. Pesavento ◽  
Michael S. Kent
Keyword(s):  
Malignant Lymphoma ◽  
Immunosorbent Assay ◽  
Feline Immunodeficiency Virus ◽  
Leukemia Virus ◽  
Feline Leukemia Virus ◽  
Enzyme Linked Immunosorbent Assay ◽  
Time Period ◽  
Immunodeficiency Virus ◽  
Vaccine Site ◽  
The Times

Six cats developed malignant lymphoma 3 to 45 months after treatment for vaccine site-associated sarcoma. During the same time period, 184 cats were evaluated in the teaching hospital for vaccine site-associated sarcomas. Feline vaccine site-associated sarcoma is not believed to be associated with feline leukemia virus (FeLV) infection. Five of six cats were negative by enzyme-linked immunosorbent assay for FeLV antigens at the times of diagnosis of both sarcoma and lymphoma, and no cats were infected with feline immunodeficiency virus.

Sign in / Sign up

Export Citation Format

Share Document